VIR BIOTECHNOLOGY INC
VIR·92764N102·US·Common Stock·Healthcare - Biotechnology-Activist
VIR (VIR BIOTECHNOLOGY INC) is held by 137 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($161.3M), SB INVESTMENT ADVISERS (UK) LTD ($98.1M), VANGUARD PORTFOLIO MANAGEMENT LLC ($82.6M). Net institutional sentiment: Bullish. In Q1 2026, 1 member of Congress and 105 funds bought VIR.
137
Holders
(10 Elite)
$879.9M
Total Value
73% (144)
Consensus
105 buying - 39 selling
13F: Insider & Congress:
Who's Trading
InsiderSLSATO VICKI LSell $221KMay 1, 2026
InsiderDMDe Backer MarianneOther 234K shApr 29, 2026
InsiderDMDe Backer MarianneSell $664KApr 6, 2026
InsiderSLSATO VICKI LSell $200KApr 1, 2026
Showing 1-20 of 149
1 / 8
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer